Next-Generation SCS Programming Platform: Enhancing ECAP Fidelity and Objectivity to Improve Patient Experience.
Daniel J Parker, Ajay B Antony, Gregory L Smith...
https://pubmed.ncbi.nlm.nih.gov/41505067/Actively Recruiting
Led by Saluda Medical Pty Ltd · Updated on 2026-10-20
200
Participants Needed
25
Research Sites
N/A
Total Duration
Researchers are evaluating a new way to deliver treatment using the ECAP-controlled closed-loop spinal cord stimulation SCS system called the Evoke System. This study focuses on patients who experience chronic pain in the trunk andor limbs. The goal is to test and assess new software and hardware features that may improve how the Evoke System delivers treatment. Participants will use the Evoke Spinal Cord Stimulation System, which measures electrical activity called evoked compound action potentials ECAPs. The device automatically adjusts the stimulation current to keep the ECAP amplitude consistent. This study involves a single group of participants using this novel device and will continue through to study completion, which may last up to two years. During the study, participants will be monitored for changes in ECAPs measured by the Evoke System. Researchers will evaluate these changes over the course of the study to understand how the device functions with the new features. Participants will need to provide informed consent and comply with study requirements while using the device. The total participation time can last up to two years, with regular assessments conducted throughout this period.
CONDITIONS
Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain
N
Nancy O'Connell, Director, Global Clinical Operations
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Saluda Medical Pty Ltd
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 2 years
Participants use the Evoke Spinal Cord Stimulation System that measures nerve signals and adjusts stimulation automatically to maintain consistent treatment.
Regular visits throughout the study period
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Daniel J Parker, Ajay B Antony, Gregory L Smith...
https://pubmed.ncbi.nlm.nih.gov/41505067/Saluda Medical Pty Ltd
Lead Sponsor